Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Cartesian Therapeutics, Inc. (United States)
Homepage:
cartesiantherapeutics.com
Alternate names:
Cartesian Therapeutics,
Cartesian Therapeutics, Inc.
ROR:
0254pgf38
OpenAlex ID:
I4405267315
Works
33
Awards
6
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
2023
·
Volkan Granit
, Michael Benatar
, et al.
·
The Lancet Neurology
·
306
PDF
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
2020
·
Liang Lin
, Shih-Feng Cho
, et al.
·
Leukemia
·
93
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
2026
·
Tuan Vu
, Hacer Durmus
, et al.
·
Nature Medicine
·
38
Engineering CAR-T therapies for autoimmune disease and beyond
2024
·
Emily P. English
, Rachel N. Swingler
, et al.
·
Science Translational Medicine
·
36
Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020
2022
·
Miloš D. Miljković
, Jordan E. Tuia
, et al.
·
JAMA Internal Medicine
·
35
PDF
Cancer Drug Price and Novelty in Mechanism of Action
2023
·
Miloš D. Miljković
, Jordan Tuia
, et al.
·
JAMA Network Open
·
28
PDF
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial
2026
·
Renee R. Fedak
, Rachel N. Ruggerie
, et al.
·
Nature Medicine
·
24
PDF
Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis
2025
·
Nizar Chahin
, Gregory Sahagian
, et al.
·
Annals of Clinical and Translational Neurology
·
19
PDF
Twelve-Month Follow-Up of Patients With Generalized Myasthenia Gravis Receiving BCMA-Directed mRNA Cell Therapy
2024
·
Nizar Chahin
, Gregory Sahagian
, et al.
·
medRxiv
·
15
PDF
What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015–2020)
2022
·
Kristina Jenei
, Alyson Haslam
, et al.
·
BMJ Open
·
14
PDF
Safety and Tolerability of BCMA-Directed mRNA CAR T-Cell Therapy in Multiple Myeloma and Autoimmune Disease
2024
·
Milos D Miljkovic
, Adam S. Asch
, et al.
·
Blood
·
12
CD8+ Anti-BCMA mRNA CAR T-Cells Effectively Kill Human Multiple Myeloma Cells In Vitro and In Vivo
2017
·
Liang Lin
, Lijie Xing
, et al.
·
Blood
·
8
PET scan for the detection of histological transformation of follicular lymphoma: A systematic review of diagnostic performance
2025
·
Marc Sorigue
, Milos Miljkovic
, et al.
·
Blood Reviews
·
7
A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma
2024
·
Max J. Gordon
, Sigrid Dubois
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
6
PDF
Flow cytometry to detect bone marrow involvement by follicular lymphoma
2022
·
Mercè Aren
, Silvia Marce
, et al.
·
Cytometry Part B Clinical Cytometry
·
6
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies
2024
·
Max J. Gordon
, Sigrid Dubois
, et al.
·
Blood Neoplasia
·
5
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders
2022
·
Nadia Güell
, Pablo Mozas
, et al.
·
Critical Reviews in Clinical Laboratory Sciences
·
4
Transforming bioengineering with unbiased teams and tools
2023
·
Christopher M. Jewell
, Miloš D. Miljković
, et al.
·
Nature Reviews Bioengineering
·
3
PDF
Paxlovid: A Regulatory Gamble
2023
·
Miloš D. Miljković
, Vinay Prasad
·
The American Journal of Medicine
·
3
PDF
Preclinical evaluation of CD8+ Anti-BCMA mRNA CAR T-Cells for control of multiple myeloma
2019
·
Liang Lin
, Lijie Xing
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma
2026
·
Max J. Gordon
, Milos D. Miljkovic
, et al.
·
Blood Advances
·
2
PDF
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cues
2025
·
C. Andrew Stewart
, Shaji Daniel
, et al.
·
Nature Biomedical Engineering
·
2
Efficacy and Safety of Autologous BCMA-directed mRNA CAR T-Cell Therapy in Generalized Myasthenia Gravis: Results from a Phase 2b Randomized Placebo-controlled Trial (S34.002)
2025
·
Tuan Vu
, Hacer Durmus Tekce
, et al.
·
Neurology
·
2
Romidepsin, Azacitidine, Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-Cell Lymphoma
2024
·
Max J Gordon
, Milos D Miljkovic
, et al.
·
Blood
·
2
Nociceptive and Transcriptomic Responses in a Swine Diabetic Wound Model Treated With a Topical Angiotensin 1 Receptor Antagonist
2023
·
Miriam N. Weiss
, Evelina Mocci
, et al.
·
Nursing Research
·
2
Show more works
View as search
Works count:
33
Citation count:
4,960
Year
Topic
Type
